Last Updated: June 22, 2026

ARFORMOTEROL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Arformoterol patents expire, and when can generic versions of Arformoterol launch?

Arformoterol is a drug marketed by Aiping Pharm Inc, Alembic, Aucta, Cipla, Dr Reddys, Glenmark Pharms Ltd, Lexenpharm, Lupin, Mankind Pharma, Micro Labs, Neocubes Pharma, Ritedose Corp, Saba Ilac Sanayi, Slate Run Pharma, Sun Pharm, Teva Pharms Usa, and Wilshire Pharms Inc. and is included in seventeen NDAs.

The generic ingredient in ARFORMOTEROL is arformoterol tartrate. There are four drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the arformoterol tartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Arformoterol

A generic version of ARFORMOTEROL was approved as arformoterol tartrate by CIPLA on June 22nd, 2021.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for ARFORMOTEROL?
  • What are the global sales for ARFORMOTEROL?
  • What is Average Wholesale Price for ARFORMOTEROL?
Summary for ARFORMOTEROL
US Patents:0
Applicants:17
NDAs:17
Drug Prices: Drug price information for ARFORMOTEROL
DailyMed Link:ARFORMOTEROL at DailyMed
Drug patent expirations by year for ARFORMOTEROL
Drug Prices for ARFORMOTEROL

See drug prices for ARFORMOTEROL

US Patents and Regulatory Information for ARFORMOTEROL

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aiping Pharm Inc ARFORMOTEROL TARTRATE arformoterol tartrate SOLUTION;INHALATION 214901-001 Apr 2, 2024 AN RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Lexenpharm ARFORMOTEROL TARTRATE arformoterol tartrate SOLUTION;INHALATION 218156-001 Nov 18, 2024 AN RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Cipla ARFORMOTEROL TARTRATE arformoterol tartrate SOLUTION;INHALATION 207306-001 Jun 22, 2021 AN RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ritedose Corp ARFORMOTEROL TARTRATE arformoterol tartrate SOLUTION;INHALATION 214736-001 Mar 2, 2022 AN RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Lupin ARFORMOTEROL TARTRATE arformoterol tartrate SOLUTION;INHALATION 213068-001 Feb 7, 2022 AN RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teva Pharms Usa ARFORMOTEROL TARTRATE arformoterol tartrate SOLUTION;INHALATION 200293-001 Nov 9, 2021 AN RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Slate Run Pharma ARFORMOTEROL TARTRATE arformoterol tartrate SOLUTION;INHALATION 213762-001 Jun 22, 2021 AN RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

DrugChatter Q&A for ARFORMOTEROL
Arformoterol tartrate cost?
Arformoterol tartrate and budesonide?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links